|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, September 18, 2017 ) According to the report Europe Remote Patient Monitoring Market, published by Market Data Forecast the Market was worth USD 8.22 billion in 2016 and estimated to be growing at a CAGR of 13.2%, to reach USD 15.27 billion by 2021. Europe accounts for the second largest market share in the global market.
Taking healthcare home is an evolving drift in the healthcare industry amidst increasing concerns over the geriatric population and costs sustained in the care of people enduring from chronic illness. Eminence and benefits of the remote patient monitoring technology is making it progressively attractive to vendors all over the continent. Remote patient monitoring has the ability to modify the way patients handle their own conditions so that they come to be the keepers of their own healthcare.
Browse market data tables and in-depth TOC of the Europe Remote Patient Monitoring Industry to 2021 @ http://www.marketdataforecast.com/market-reports/europe-remote-patient-monitoring-market-686/
Healthcare schemes in Europe are strained due to an elderly population and a growing number of chronic disease patients. This triggers tremendous cost pressures to swing from acute care situations to lower cost settings, comprising of a patient’s home. These are few factors driving the Remote patient monitoring market. The major limitations are the unsteady and uneven reimbursement strategies in this region.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/europe-remote-patient-monitoring-market-686/request-sample
The Europe remote patient monitoring market is segmented on the basis of type into breath monitors, physical activity monitors, heart monitors, haematological monitors and multi-sign monitors. Based on application the market is segregated into cancer treatment, cardiovascular diseases, diabetes treatment, sleep disorder and weight management and fitness monitoring. On the basis of end users market is bifurcated into ambulatory care centers, hospitals and home healthcare. The increasing occurrence of diabetes is a major factor that is predicted to increase the demand for haematology monitoring devices in the global remote patient monitoring devices market.
Based on geography the market is analysed under various regions namely, U.K, Italy, Spain, France and Germany. In recent years, the U.K. has advanced extensively in remote patient monitoring, which is estimated to increase the market, in terms of value.
Inquire before buying @ http://www.marketdataforecast.com/market-reports/europe-remote-patient-monitoring-market-686/inquire
The market contributors involve in mergers and attainments along with new product enhancement in an effort to preserve sustainability. Some key players include Welch Allyn, Bosch, Johnson & Johnson, Intel, Roche, Philips Healthcare, Philips, Healthanywhere Inc, Honeywell, American Telecare, Biotronik, and Covidien Plc.
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
